No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Amgen Sues Accord and Intas in Fifth US BPCIA Denosumab Patent Suit; Seeks to Consolidate Proceedings
On 13 November 2024, Amgen filed a BPCIA Complaint for Patent Infringement in the US District Court for the Eastern District of North Carolina against Accord Biopharma, Accord Healthcare and Intas Pharmaceuticals. The Complaint asserts infringement of 34 of Amgen’s...